Why Are Neuland Labs' Quarterly Numbers So Volatile? CEO Saharsh Davuluri Explains
CNBC-TV18 · 23 Sept 2026 · 1 min
Management interview of Neuland Laboratories Ltd (NEULANDLAB).
- Saharsh Davuluri, CEO, Neuland Laboratories Ltd
Neuland Labs CEO Saharsh Davuluri explained that quarterly lumpiness stems from being a small- to mid-sized company reliant on three or four major molecules. When shipments of one key molecule miss a quarter, it creates a downward effect. Furthermore, the company manufactures small- to mid-volume niche molecules where formulator clients do not schedule manufacturing quarterly, but rather run campaigns once or twice a year.